Your session is about to expire
Truvada vs Viread
Introduction
For patients with HIV or those at high risk of contracting this virus, certain antiretroviral drugs that inhibit the replication and spread of the virus in their bodies can play a crucial role in managing symptoms and reducing transmission. Truvada and Viread are two such drugs commonly prescribed for HIV treatment or prevention. They each affect different stages of the viral lifecycle but both help to control viral loads within patients. Truvada is a combination drug containing emtricitabine and tenofovir disoproxil fumarate (the active ingredient of Viread), providing dual-action against the virus by interfering with its ability to replicate on multiple levels. On the other hand, Viread contains only tenofovir disoproxil fumarate which targets an enzyme called reverse transcriptase that's used by HIV during infection to convert its genetic material into DNA, thus preventing it from multiplying further.
What is Truvada?
Truvada and Viread are both antiviral medications used to combat HIV infection. They each contain the active ingredient tenofovir, which is instrumental in preventing the replication of HIV cells within the body. Truvada, however, combines tenofovir with another compound called emtricitabine for an enhanced effect.
Truvada was approved by the FDA in 2004 as a pioneering class of combination therapies designed to suppress viral loads more effectively than single drug regimens like Viread alone. It's not only prescribed for people living with HIV but also as a pre-exposure prophylaxis (Prep) for at-risk individuals who are not infected yet.
While both drugs can cause side effects such as nausea or kidney issues, these tend to be less frequent and severe with Truvada due its dual-action formulation that allows lower doses of each component drug. However, it's critical that any changes in medication regimen should be guided by medical professionals considering individual patient factors.
What conditions is Truvada approved to treat?
Truvada is approved for the treatment of various conditions related to HIV:
- As part of combination therapy in adults and children weighing at least 17 kg who are infected with HIV
- For pre-exposure prophylaxis (Prep) to reduce the risk of sexually acquired HIV infection in adults and adolescents who weigh at least 35 kg, including those at high risk.
Viread, on the other hand, is used:
- In combination with other antiretroviral agents for treating HIV-1 infection in pediatric patients aged two years old or older and adult patients.
- It's also indicated for treatment of chronic hepatitis b in adults and pediatric patients twelve years old or older.
How does Truvada help with these illnesses?
Truvada helps manage HIV infection by reducing the amount of virus in the body. It does this by blocking an enzyme called reverse transcriptase, which HIV uses to replicate itself. By inhibiting this enzyme, Truvada interferes with the virus's ability to multiply and spread throughout the body. Reverse transcriptase is a type of RNA-dependent DNA polymerase that plays a crucial role in viral production within host cells. It is thought that individuals with untreated HIV have relatively high levels of viral replication. Therefore, by inhibiting reverse transcriptase, Truvada can limit the negative effects of HIV and help patients manage their condition and stabilize their health status.
It should be noted that while Viread (Tenofovir) is one component of Truvada, Truvada also contains another antiviral medication called Emtricitabine-- together they offer a combination approach to treating HIV.
What is Viread?
Viread is a brand name for tenofovir disoproxil, an antiviral medication used to prevent and treat HIV/AIDS and chronic hepatitis b. It works through nucleotide reverse transcriptase inhibition, which means it prevents the virus from multiplying in the body by inhibiting its DNA replication process.
Viread was first approved by the FDA in 2001. As Viread is not a protease inhibitor or integrase strand transfer inhibitor, it does not block the action of these vital viral proteins. This difference in mechanism of action also leads to a different side-effect profile compared to other classes of antiretroviral drugs; namely, it does not cause lipodystrophy (a common side effect with some other HIV medications) and has less impact on lipid levels.
The effects of tenofovir can be beneficial for treating HIV infection especially when combined with other antivirals - similar to Truvada which combines two active ingredients including tenofovir - as part of an effective antiretroviral therapy regimen. Importantly though, Viread should never replace safer sex practices as it cannot guarantee protection against transmission of HIV or hepatitis B.
What conditions is Viread approved to treat?
Viread is approved for the treatment of:
- Chronic Hepatitis b, an infectious disease that affects the liver
- HIV infection, it's not a cure but when taken as part of an antiretroviral therapy regimen, it can help to control HIV infection and decrease the risk of progression to more serious conditions.
How does Viread help with these illnesses?
Tenofovir disoproxil fumarate (TDF) is an antiviral drug that plays a crucial role in the treatment of HIV infection and chronic hepatitis b. It works by inhibiting viral replication, helping to lower the amount of virus in your body. Viread, which contains TDF as its active ingredient, has been shown to effectively suppress viral loads and increase CD4 cell counts in people with HIV. Like Truvada, it can be used for pre-exposure prophylaxis (Prep) to prevent HIV infection in high-risk populations. However, it's important to note that while Truvada combines two drugs - emtricitabine and tenofovir disoproxil fumarate - Viread only consists of tenofovir disoproxil fumarate. This means that unlike Truvada which may offer broader coverage against viruses due to the combination therapy approach, Viread focuses solely on leveraging the effects of TDF.
How effective are both Truvada and Viread?
Both Truvada and Viread have established histories of success in treating patients with HIV, and they were initially approved by the FDA only a few years apart. Since they act on different stages of the virus lifecycle, they may be prescribed under different circumstances. The effectiveness of Truvada and Viread in managing HIV was directly studied in several clinical trials; both drugs exhibited similar efficacy along with comparable safety profiles.
A 2004 review on Viread demonstrated that it is effective at reducing viral load from the early stages of treatment. Its side effect profile is generally favorable over many other antiviral drugs, with kidney damage being a rare but serious potential side effect to note. The same study reports that Viread has become one of the most-prescribed antiviral drugs worldwide due to its potent action against HIV.
Truvada, which contains two active ingredients including tenofovir (the active ingredient in Viread), was shown in a 2016 meta-analysis to be more effective than placebo as pre-exposure prophylaxis for high-risk populations such as men who have sex with men or transgender women. It's also used effectively for individuals living with an infected partner. Significant research on its use involves Truvada co-prescribed alongside other antivirals, so data confirming its efficacy as a stand-alone treatment is less robust than that for Viread alone. Furthermore, evidence supporting Truvada significantly augmenting the effects of other antivirals remains somewhat limited compared to single-drug treatments like Viread. Nonetheless, due to its combined pharmacology strategy targeting multiple parts of the virus life cycle simultaneously, Truvada may be an optimal choice for patients who need more aggressive therapy or those seeking preventive measures against contracting HIV.
At what dose is Truvada typically prescribed?
Oral dosages of Truvada and Viread for the treatment of HIV-1 infection in adults and pediatric patients weigh at least 17kg differ. For Truvada, it is recommended to take one tablet (containing 200mg of emtricitabine and 300mg of tenofovir disoproxil fumarate) once a day. For Viread, adults should take one 300 mg tablet daily while pediatric patients' dosage varies based on weight. The dose can be adjusted after a few weeks if there is inadequate response. However, exceeding the maximum recommended dosage could lead to potential side effects or drug resistance.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Viread typically prescribed?
Viread treatment typically commences with a dosage of 300mg/day for adults and adolescents (weighing at least 35kg). For children weighing between 17 to less than 35 kg, the dose is adjusted based on body weight. This medication is usually taken once daily, without regard to food intake. The maximum recommended dose per day is 300 mg. If there are no signs of improvement or if the condition worsens after a few weeks, your healthcare provider may reassess your treatment plan and make necessary adjustments. Remember that any changes in dosage should only be made under medical supervision to ensure safety.
What are the most common side effects for Truvada?
Common side effects of both Truvada and Viread may include:
- Diarrhea, nausea, stomach pain or discomfort
- Fatigue (general weakness and tiredness)
- Headache
- Dizziness
- Depression, anxiety, strange dreams
- Rash or itchiness
- Changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts) Insomnia (trouble sleeping)
It should be noted that these are not all the side effects that can occur. If you experience any unusual symptoms while taking these medications do not hesitate to contact healthcare professional immediately.
Are there any potential serious side effects for Truvada?
In rare instances, both Truvada and Viread may cause serious side effects such as:
- New or worsening kidney problems, including kidney failure: Symptoms might include shortness of breath, swelling in your ankles or feet, feeling tired.
- Lactic acidosis (a serious metabolic condition): Signs to watch for are unusual muscle pain, trouble breathing, stomach pain with nausea and vomiting.
- Severe liver issues: Look out for symptoms like dark urine coloration, loss of appetite leading to severe weight loss over a short period of time; jaundice – yellowing skin or the whites of the eyes
- Bone problems: Fractures and bone thinning or softening can occur especially if you have a history of bone fractures.
- Changes in body fat distribution If any signs manifest themselves while on either Truvada or Viread medication therapy regimen should be immediately reported to your healthcare provider. Also note that these medications don’t prevent HIV transmission so safe practices are still necessary even when taking them.
What are the most common side effects for Viread?
Potential side effects of Viread can include:
- Digestive issues such as nausea, vomiting, stomach pain, and loss of appetite
- Headache or dizziness
- Mild rash
- Changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts and waist)
- Decreased bone mineral density leading to muscle or joint pain Please note that this is not a complete list; some users may experience other side effects. Always consult with your healthcare provider if you notice any unusual changes while on medication.
Are there any potential serious side effects for Viread?
Viread, while effective in treating HIV and hepatitis b infections, can lead to some severe side effects. You should consult a healthcare professional immediately if you experience:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue or throat
- Lactic acidosis symptoms that include muscle pain or weakness; numbness or cold feeling in your arms and legs; trouble breathing; stomach pain, vomiting, irregular heartbeat
- Liver problems - upper right part abdominal pain; yellowing eyes/skin (jaundice); dark urine
- New infections - fever, night sweats, swollen glands in the neck/armpits/groin area
- Kidney problems - little or no urination at all accompanied by painful/difficult urination with swollen feet/ankles It is important to monitor for these symptoms while using Viread because they may require prompt medical attention.
Contraindications for Truvada and Viread?
Both Truvada and Viread, like most antiviral medications, may cause serious side effects. If you notice worsening symptoms such as persistent nausea/vomiting, abdominal pain, dark urine or yellowing of the skin/eyes (signs of liver problems), loss of appetite or unexplained weight loss (signs of kidney problems), please seek immediate medical attention.
Neither Truvada nor Viread should be taken if you are using other drugs that can harm your kidneys. This includes non-prescription/prescription drugs and herbal products. Always inform your doctor about all the medicines you're taking; certain harmful interactions could occur with Truvada and Viread.
Particularly important is to avoid taking Hepatitis b medicines without discussing it with your healthcare provider. Stopping TRUVADA or VIREAD can cause serious hepatitis B symptoms to reappear, which in some cases may become life-threatening.
How much do Truvada and Viread cost?
For the brand name versions of these drugs:
- The price for Truvada, which contains two antiretroviral medications (emtricitabine and tenofovir disoproxil fumarate), averages around $2,000 for a 30-tablet supply. This works out to approximately $67 per day.
- Viread (tenofovir disoproxil fumarate) costs about $1,100 for 30 tablets or roughly $37 per day.
Thus, if you are taking both medications within Truvada separately, it is more cost-effective to use the combination tablet. However, your personal medical history and potential side effects should be primary considerations in determining which of these drugs is right for you.
As with most medications, generic versions offer significant savings:
- Tenofovir Disoproxil Fumarate/Emtricitabine (the generic alternative to Truvada) can cost as low as about $25 per pill depending on the pharmacy offering it.
- Generic Viread (Tenofovir Disoproxil Fumarate) may be available at prices starting from around $15 per pill.
Please note that prices vary widely based on insurance coverage and location.
Popularity of Truvada and Viread
Truvada and Viread are both widely used in the treatment and prevention of HIV. Truvada, a combination drug containing tenofovir disoproxil fumarate (the active ingredient in Viread) and emtricitabine, was estimated to have been prescribed to about 200,000 people as pre-exposure prophylaxis (Prep) for HIV in the US in 2020. This accounts for just over half of all PrEP prescriptions within that year.
Viread alone is an effective antiviral medication but it's often combined with other drugs such as lamivudine or emtricitabine in single-tablet regimens like Truvada or Atripla because of its synergistic effects. In 2020, Viread was prescribed to roughly 1 million people across various indications including chronic hepatitis b infection alongside its use against HIV. The prevalence of these two medications has remained relatively steady over the last decade due to their effectiveness at managing viral loads and preventing progression from HIV to AIDS.
Conclusion
Both Truvada (emtricitabine/tenofovir disoproxil fumarate) and Viread (tenofovir disoproxil fumarate) are antiviral medications used in the treatment and prevention of HIV infection. They have both demonstrated effectiveness through numerous clinical studies and trials, proving more effective than placebo treatments at reducing viral loads in patients. While each drug can be used individually, they may be combined with other antiretroviral drugs for a more comprehensive approach to combatting HIV.
Truvada is generally recommended as a first-line therapy due to its combination of two active substances -- emtricitabine and tenofovir -- providing dual modes of action against the virus. On the other hand, Viread - containing only tenofovir - is usually considered when Truvada cannot be tolerated or used due to contraindications or side effects.
Both drugs are available in generic form, making them affordable options for patients who must pay out-of-pocket. The adjustment period for both medicines varies depending on individual responses; initial effects may not always be immediately noticeable.
The side-effect profiles are comparable between these two drugs, although Truvada might present additional risks associated with an extra active ingredient (emtricitabine). Both treatments are typically well-tolerated but can cause kidney problems or bone density reduction over time. For this reason, regular monitoring by healthcare professionals is essential when taking these medications.